Ketamine / KAPPending re-verificationDesignated-centers model

Privatklinik Meiringen (ketamine programme)

Meiringen, Switzerland

Treatment & access

  • Treatments offeredKetamine therapy (intravenous and nasal) · S-ketamine (esketamine) · Electroconvulsive therapy (ECT) · rTMS (repetitive transcranial magnetic stimulation) · tDCS (transcranial direct current stimulation)
  • Access routeprivate_pay
  • Price informationNo ketamine-specific prices are published. On its tariffs page the clinic states it is a listed hospital (cantonal hospital lists of Bern, Obwalden, Nidwalden, Fribourg and Solothurn) open to all insurance categories including basic-insured patients; inpatient treatment costs are covered by canton and insurer under the statutory cost split, with a possible small daily-rate difference payable by basic-insured patients from some cantons unless they hold supplementary insurance. The clinic files the cost approval request with the insurer after referral.
  • Phone+41 33 972 81 11
  • Websitehttps://privatklinik-meiringen.ch

About this provider

Privatklinik Meiringen is a private psychiatric hospital in the Bernese Oberland offering ketamine therapy within its portfolio of extended therapy procedures. The clinic provides ketamine intravenously and nasally, as well as S-ketamine (Swissmedic-approved since 2020), for patients with treatment-resistant depression, and offers participation in a clinical multicentre study using oral extended-release ketamine. Therapies are closely monitored, and the indication is carefully established and weighed by physicians. The clinic is recognised by the Swiss Society for Interventional Psychiatry (SGIP-SSPI), which it describes as standing for the highest quality standards in the indication and delivery of interventional therapies. Other interventional options on site include electroconvulsive therapy, rTMS (used at the clinic since 2012) and tDCS.

Services & programs

  • Ketamine therapy (IV and nasal) and S-ketamineFor patients with treatment-resistant depression; closely controlled and monitored, with the indication carefully established by physicians. S-ketamine has been Swissmedic-approved since 2020. Not published on the provider's website.
  • Electroconvulsive therapy (ECT)Described by the clinic as a well-researched, safe method for severe, treatment-resistant psychiatric illness, delivered under anesthesia. Not published on the provider's website.
  • rTMSThe clinic states it has taken a pioneering role in Switzerland in applying transcranial magnetic stimulation since 2012, mainly for treatment-resistant depression, anxiety, movement and obsessive-compulsive disorders. Not published on the provider's website.
  • tDCSNon-invasive transcranial direct current stimulation using a Flow Neuroscience headset, used as an add-on treatment for depression and anxiety. Not published on the provider's website.

Programs & studies

ProgramKindStatus
Ketamine / S-ketamine therapy
IV and nasal ketamine plus S-ketamine (Swissmedic-approved since 2020) for treatment-resistant depression.
ketamine_iv_and_nasaloffered
Oral extended-release ketamine multicentre study
The clinic states patients will have the opportunity to take part in a clinical multicentre study using oral extended-release ketamine.
clinical_trialparticipation offered
SGIP-SSPI recognition
The clinic is recognised by the Swiss Society for Interventional Psychiatry (SGIP-SSPI) for quality standards in indication and delivery of interventional therapies.
quality_recognitionrecognised

Pricing

ItemPrice
Inpatient treatment
Listed hospital: costs covered by canton and insurer per statutory cost split; basic-insured patients from some cantons may pay a small daily-rate difference unless they hold general/semi-private/private supplementary insurance. Detailed tariff information via patient admissions, +41 33 972 85 65.
Not published

Prices are taken from the provider's own website and were last checked on . Always confirm the current price with the provider before booking.

Facilities & languages

  • Facilities
    • Inpatient private psychiatric clinic with hotel-style rooms and catering
    • Reception staffed daily 08:00-20:00; 24-hour emergency line +41 33 972 85 67
  • LanguagesWebsite in German with an English version.
  • TeamNamed contact for ketamine therapy is Armend Ademaj, senior physician (Oberarzt); extended therapy procedures are led by designated specialists.

Common questions

Is treatment at Privatklinik Meiringen covered by Swiss insurance?

The clinic is a listed hospital on the hospital lists of Bern, Obwalden, Nidwalden, Fribourg and Solothurn and is open to all patients regardless of insurance category, including those with basic insurance only. Inpatient costs are covered by the canton of residence and the insurer under a fixed cost split; in some cantons basic-insured patients may owe a small daily-rate difference unless they hold supplementary insurance. Ketamine-specific prices are not published.

How does admission work?

After a referral to the clinic, the clinic itself submits the cost approval request to the relevant health insurer. A physician referral form is available on the website, and patient admissions can be reached at +41 33 972 85 65.

Is ketamine therapy inpatient or outpatient?

Privatklinik Meiringen is primarily an inpatient clinic; ketamine therapy is offered as part of its extended therapy procedures during treatment there. The website does not describe a standalone outpatient ketamine track.

Who decides whether ketamine is appropriate?

The clinic states that the indication for ketamine therapy is carefully established and weighed by physicians, and that therapies are closely controlled and monitored.

Which forms of ketamine are available?

Intravenous and nasal ketamine as well as S-ketamine (Swissmedic-approved since 2020), plus the possibility to participate in a multicentre clinical study of oral extended-release ketamine.

Looking at alternatives? Other Swiss routes include BAG-designated Spravato (esketamine) centres with insurer coverage, providers holding federal limited medical use authorisations for psychedelic-assisted therapy, and clinical trials at university psychiatric clinics.

Verification

This record was verified previously and is awaiting its scheduled re-check against the registry.

Spotted an error? See our methodology for how records are checked and how to report a correction.